- August 12, 2022
- Newsletter
- 617-430-5616
Menu
» Home » Drug Database » Corticosteroids A1 » budesonide (oral inhalation)
ADVERTISEMENT
ADVERTISEMENT
» Home » Drug Database » Corticosteroids A1 » budesonide (oral inhalation)
Brand Name :
Pulmicort nebuamp, Pulmicort turbuhaler, Pulmicort flexhaler
Synonyms :
budesonide
Class :
Drugs for asthma and COPD & Corticosteroid (Inhalant)
No drug interaction found for budesonide (oral inhalation) and .
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Immune Checkpoint Inhibitors.
Corticosteroids may diminish the therapeutic effect of Vaccines
vaccinia immune globulin intravenous (Rx)
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
Corticosteroids may diminish the therapeutic effect of Vaccines
poliovirus vaccine, live, trivalent
corticosteroids may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
corticosteroids may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
measles mumps and rubella vaccine, live
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
vaccinia immune globulin intravenous (Rx)
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may enhance the risk of adverse/toxic effect of rubella- or varicella-containing live vaccines
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may reduce the therapeutic effect of immune checkpoint inhibitors
may have an increasingly adverse effect when combined with car-t cell immunotherapy
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
choline magnesium trisalicylate
salicylates may increase the adverse effect of corticosteroids
corticosteroids may enhance the immunosuppressive effect of abrocitinib
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
may increase the immunosuppressive effects of corticosteroids
may increase the immunosuppressive effect
may increase the toxic effect
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may increase the tacrolimus immunosuppressive effect
may have an increased immunosuppressive effect when combined with upadacitinib
may enhance the serum concentration of CYP3A4 Inhibitors
may decrease the therapeutic effect of hyaluronidase
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
may diminish the bioavailability of Antacids
aluminum hydroxide/magnesium carbonate
may decrease the bioavailability of antacids
may diminish the antineoplastic effect when combined
may decrease the diagnostic effect when combined with metyrapone
may have an increased immunosuppressive effect when combined with abrocitinib
may have an increased immunosuppressive effect when combined with baricitinib
may decrease the diagnostic effect when combined with coccidioides skin test
may decrease the therapeutic effect when combined with covid-19 vaccine
may have an increased immunosuppressive effect when combined with corticosteroids
may have an increased anticoagulant effect when combined with desirudin
may have an increased immunosuppressive effect when combined with corticosteroids
may decrease the therapeutic effect when combined with influenza virus vaccines
may have an increased immunosuppressive effect when combined with leflunomide
sipuleucel-T: they may decrease the therapeutic effect of corticosteroids
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
may decrease the therapeutic effect of each other when combined
corticosteroids may diminish the antineoplastic effect of Aldesleukin
measles, mumps, rubella and varicella vaccine, live
may increase the toxic effects of varicella virus containing vaccine
they enhance the toxicity of rubella or varicella-containing live vaccines
they enhance the toxicity of rubella or varicella-containing live vaccines
may diminish the anti-neoplastic activity
may diminish the diagnostic effect of macimorelin
may increase the hyponatremic effect of corticosteroids
may decrease the antineoplastic effect when combined with aldesleukin
may have an increasingly adverse effect when combined with talimogene laherparepvec
may decrease the antineoplastic effect when combined with aldesleukin
may have an increased hyponatremic effect when combined with desmopressin
may enhance the serum concentration when combined
may have an increasingly adverse effect when combined with BCG products
may increase the tachycardic effect of Beta2-Agonists
may have an increased immunosuppressive effect when combined with cladribine
may have an increasingly adverse effect when combined with dengue vaccine
may decrease the diagnostic effect when combined with macimorelin
may decrease the therapeutic effect when combined with corticosteroids
may have an increasingly adverse effect when combined with nadofaragene firadenovec
may have an increased immunosuppressive effect when combined with natalizumab
may have an increased immunosuppressive effect when combined with corticosteroids
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
etonogestrel/ethinyl estradiol
may increase the thrombogenic effect of Hormonal Contraceptives
corticosteroids May enhance the adverse/toxic effect of quinolones.
corticosteroids May enhance the adverse/toxic effect of quinolones.
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may diminish the therapeutic effect of immune Checkpoint inhibitors
may diminish the therapeutic effect of immune Checkpoint inhibitors
may diminish the therapeutic effect of immune Checkpoint inhibitors
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may increase the hypokalemic effect of thiazide diuretics
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of quinolones
may enhance the adverse effect of quinolones
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
synthetic conjugated estrogens, a
may increase the serum concentration
synthetic conjugated estrogens, b
may increase the serum concentration
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may decrease the therapeutic effect when combined with agents of urea cycle disorder
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
corticosteroids: they may increase the hypokalemic effect when combined with thiazides
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
may have an increasingly adverse effect when combined with acetylcholinesterase inhibitors
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
relugolix/estradiol/norethindrone
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may have an increased fluid-retaining effect when combined with androgens
may diminish the absorption when combined with corticosteroids
it may increase the risk of adverse effects of acetylcholinesterase inhibitors
it may increase the risk of adverse effects of acetylcholinesterase inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the risk of adverse effects of acetylcholinesterase Inhibitors
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
corticosteroids may increase the fluid-retaining effect of androgens
bile Acid Sequestrants May reduce the absorption of corticosteroids
Corticosteroids may reduce the therapeutic effect of Brincidofovir
corticosteroids (Systemic) may reduce the therapeutic effect of calcitriol
corticosteroids may enhance the immunosuppressive effect of cladribine
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
Corticosteroids may diminish the therapeutic effect of Growth Hormone Analogs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of NSAIDs
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
Corticosteroids may enhance the adverse/toxic effect of nonsteroidal Anti-Inflammatory agents
Corticosteroids may enhance the adverse/toxic effect of nonsteroidal Anti-Inflammatory agents
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
corticosteroids may enhance the hypokalemic effect of Thiazide and thiazide-Like diuretics
may increase the adverse/toxic effect of dengue vaccine
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may increase the fluid retaining effect
may increase the toxic effects
may increase the therapeutic effect
may increase the toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may increase the toxic effect of non-steroidal anti-inflammatory drugs
may increase the toxic effect
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
may enhance the serum concentration of nirmatrelvir and ritonavir
may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
may reduce the rate of absorption of corticosteroids
choline magnesium trisalicylate
may enhance the adverse effect of corticosteroids
may enhance the toxic effect of salicylates
may have a decreased diagnostic effect when combined with cosyntropin
may increase the hypokalemic effect of amphotericin
may have an increased hypokalemic effect when combined with amphotericin B
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may enhance the serum concentration when combined with Corticosteroids (ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
estrogens esterified/methyltestosterone
may enhance the serum concentration of estrogen derivatives
drospirenone/ethinyl estradiol/levomefolate
may enhance the serum concentration of Estrogen Derivatives
They may diminish the absorption when combined with bile acid sequestrants
may decrease the diagnostic effect when combined with cosyntropin
may enhance the serum concentration when combined with corticosteroids
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
ciprofloxacin inhaled (Pending FDA approval)
May increase the toxic effect of Quinolones
may increase the toxic effect of Acetylcholinesterase Inhibitors
may have an increased hypokalemic effect when combined with amphotericin b
may have an increasingly adverse effect when combined with antithymocyte globulin
may decrease the therapeutic effect when combined with brincidofovir
may decrease the therapeutic effect when combined with calcitriol
may decrease the therapeutic effect when combined with corticorelin
may have an increasingly adverse effect when combined with deferasirox
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
bazedoxifene/conjugated estrogens
may enhance the concentration of serum when combined with corticosteroids
synthetic conjugated estrogens, a
may enhance the concentration of serum when combined with corticosteroids
synthetic conjugated estrogens, b
may enhance the concentration of serum when combined with corticosteroids
cyproterone and ethinyl estradiol
may enhance the serum concentration of Estrogen Derivatives
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
Frequency defined:
>10%
Otitis media
Respiratory infection
Rhinitis
1% to 10%
Syncope
Chest pain
Headache
Pain
Skin rash
Fatigue
Pruritus
Weight gain
Dyspepsia
Nausea
Diarrhea
Vomiting
Abdominal
Anorexia
Emotional liability
Fatigue
Conjunctivitis
Postmarketing
Adrenocortical insufficiency
Bruise
Cataract
Depression
Glaucoma
Growth suppression
Anxiety
Throat irritation
Wheezing
Irritability
Pregnancy consideration: Suggested to be administered in controlled doses to avoid malformations in pregnant females. Budesonide can be recommended for asthma treatment during pregnancy.
Lactation: Budesonide can be excreted in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: Budesonide
Pronounced: Bu-de-so-ni-de
Why do we use budesonide?
Budesonide is a nasal corticosteroid. It is used to treat asthma and other upper respiratory allergies.
ADVERTISEMENT
» Home » Drug Database » Corticosteroids A1 » budesonide (oral inhalation)
Brand Name :
Pulmicort nebuamp, Pulmicort turbuhaler, Pulmicort flexhaler
Synonyms :
budesonide
Class :
Drugs for asthma and COPD & Corticosteroid (Inhalant)
Dosage Forms & Strengths
Aerosol Powder, Inhalant:
90 mcg/actuation
180 mcg/actuation
Suspension, Inhalant:
0.25 mg/2ml
Dosage classification:
Low dose: 200 to 400 mcg/day
Medium dose: >400 to 800 mcg/day
High dose: >800 mcg/day
Dosage Forms & Strengths
Aerosol Powder, Inhalant:
90 mcg/actuation
180 mcg/actuation
Suspension, Inhalant:
0.25 mg/2ml
Refer to adult dosing